2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Pleural Effusion, Malignant
6
Neoplasm Metastasis
4
Solitary Fibrous Tumor, Pleural
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lung Diseases
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cisplatin
6
Pemetrexed
5
cediranib
3
Chemotherapy, Adjuvant
3
Radiotherapy
2
Neoadjuvant Therapy
2
Gemcitabine
2
vatalanib
1
rilotumumab
1
pembrolizumab
1
belinostat
1
Watchful Waiting
1
Vinorelbine
1
Talc
1
Sorafenib
1
Semaxinib
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Platinum
1
Pharmacogenomic Testing
1
Methotrexate
1
Immunoenzyme Techniques
1
Gefitinib
1
Erlotinib Hydrochloride
1
Dihematoporphyrin Ether
1
Dasatinib
1
Capecitabine
1
Bevacizumab
1
ARQ 197
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Solitary Fibrous Tumor, Pleural
×
Talc
×
Clear all
NCT00821860
2013-06-28
MesoVATS
Papworth Hospital NHS Foundation Trust
Phase 3
Completed
196 enrolled